Generali Asset Management SPA SGR Acquires New Stake in Semler Scientific Inc. $SMLR

Key Points

• Generali Asset Management has acquired a new stake of 70,000 shares in Semler Scientific Inc., valued at approximately $2.7 million, representing a 0.51% ownership of the company.
• Multiple analysts have adjusted their price targets for Semler Scientific, with new targets ranging from $60 to $86, while the stock currently has an average rating of "Moderate Buy."
• Semler Scientific recently reported a significant earnings beat with $5.04 EPS for the quarter, exceeding analysts' expectations and reflecting a strong net margin of 86.20%.

Generali Asset Management SPA SGR acquired a new stake in Semler Scientific Inc. (NASDAQ:SMLR - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 70,000 shares of the company's stock, valued at approximately $2,712,000. Generali Asset Management SPA SGR owned 0.51% of Semler Scientific at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Summit Securities Group LLC purchased a new stake in Semler Scientific during the 1st quarter worth about $32,000. SBI Securities Co. Ltd. increased its holdings in Semler Scientific by 161.3% during the 1st quarter. SBI Securities Co. Ltd. now owns 959 shares of the company's stock worth $35,000 after purchasing an additional 592 shares during the period. Corebridge Financial Inc. increased its holdings in Semler Scientific by 39.7% during the 1st quarter. Corebridge Financial Inc. now owns 3,298 shares of the company's stock worth $119,000 after purchasing an additional 938 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Semler Scientific by 47.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,965 shares of the company's stock worth $144,000 after purchasing an additional 1,269 shares during the period. Finally, MetLife Investment Management LLC increased its holdings in Semler Scientific by 37.2% during the 1st quarter. MetLife Investment Management LLC now owns 4,134 shares of the company's stock worth $150,000 after purchasing an additional 1,120 shares during the period. Hedge funds and other institutional investors own 49.37% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Maxim Group cut their price target on Semler Scientific from $95.00 to $80.00 and set a "buy" rating on the stock in a report on Friday, September 19th. Benchmark cut their price target on Semler Scientific from $101.00 to $86.00 and set a "buy" rating on the stock in a report on Tuesday, September 23rd. Weiss Ratings restated a "hold (c)" rating on shares of Semler Scientific in a report on Wednesday, October 8th. Finally, Cantor Fitzgerald dropped their price objective on Semler Scientific from $61.00 to $60.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Semler Scientific currently has an average rating of "Moderate Buy" and an average target price of $74.25.

Semler Scientific Stock Down 3.1%

Shares of NASDAQ SMLR opened at $24.67 on Friday. The stock has a market cap of $373.50 million, a PE ratio of 10.15 and a beta of 1.41. The company has a quick ratio of 0.58, a current ratio of 0.60 and a debt-to-equity ratio of 0.25. Semler Scientific Inc. has a 52-week low of $23.51 and a 52-week high of $81.56. The business has a 50-day moving average price of $30.05 and a 200 day moving average price of $34.44.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its earnings results on Monday, August 4th. The company reported $5.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $5.31. The firm had revenue of $8.22 million during the quarter, compared to analysts' expectations of $8.10 million. Semler Scientific had a return on equity of 43.84% and a net margin of 86.20%.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.